These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 15273110)
1. Pharmacodynamic evaluation of the neutralization of endotoxin by PMX622 in mice. Lake P; DeLeo J; Cerasoli F; Logdberg L; Weetall M; Handley D Antimicrob Agents Chemother; 2004 Aug; 48(8):2987-92. PubMed ID: 15273110 [TBL] [Abstract][Full Text] [Related]
2. Modification of tumor necrosis factor-induced acute toxicity D-galactosamine challenge by polymyxin B, an anti-endotoxin. Sakaguchi S; Furusawa S; Yokota K; Takayanagi M; Takayanagi Y Int J Immunopharmacol; 2000 Nov; 22(11):935-42. PubMed ID: 11090702 [TBL] [Abstract][Full Text] [Related]
3. Covalent polymyxin B conjugate with human immunoglobulin G as an antiendotoxin reagent. Drabick JJ; Bhattacharjee AK; Hoover DL; Siber GE; Morales VE; Young LD; Brown SL; Cross AS Antimicrob Agents Chemother; 1998 Mar; 42(3):583-8. PubMed ID: 9517936 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of a polymyxin B-dextran 70 conjugate in experimental model of endotoxemia. Bucklin SE; Lake P; Lögdberg L; Morrison DC Antimicrob Agents Chemother; 1995 Jul; 39(7):1462-6. PubMed ID: 7492086 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of endotoxin by polymyxin B. Cooperstock MS Antimicrob Agents Chemother; 1974 Oct; 6(4):422-5. PubMed ID: 4157338 [TBL] [Abstract][Full Text] [Related]
6. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo. Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530 [TBL] [Abstract][Full Text] [Related]
7. Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary. Silverstein R; Turley BR; Christoffersen CA; Johnson DC; Morrison DC J Exp Med; 1991 Feb; 173(2):357-65. PubMed ID: 1988538 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of polymyxin B in an ex vivo model of endotoxemia in horses. Parviainen AK; Barton MH; Norton NN Am J Vet Res; 2001 Jan; 62(1):72-6. PubMed ID: 11197565 [TBL] [Abstract][Full Text] [Related]
9. Polymyxin B protects horses against induced endotoxaemia in vivo. Barton MH; Parviainen A; Norton N Equine Vet J; 2004 Jul; 36(5):397-401. PubMed ID: 15253079 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of polymyxin B sulfate in experimental meningococcal infection in mice. Bannatyne RM; Harnett NM; Cheung R Can J Microbiol; 1977 Nov; 23(11):1526-8. PubMed ID: 200329 [TBL] [Abstract][Full Text] [Related]
11. Systemic hypoglycemia following central injection of endotoxin in mice. Amir S; Harel M Brain Res; 1985 Jul; 339(2):382-5. PubMed ID: 3896402 [TBL] [Abstract][Full Text] [Related]
12. Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant. Sil D; Shrestha A; Kimbrell MR; Nguyen TB; Adisechan AK; Balakrishna R; Abbo BG; Malladi S; Miller KA; Short S; Cromer JR; Arora S; Datta A; David SA Antimicrob Agents Chemother; 2007 Aug; 51(8):2811-9. PubMed ID: 17548488 [TBL] [Abstract][Full Text] [Related]
13. Polymyxin B-conjugated alpha 2-macroglobulin as an adjunctive therapy to sepsis: Modes of action and impact on lethality. Birkenmeier G; Nicklisch S; Pockelt C; Mossie A; Steger V; Gläser C; Hauschildt S; Usbeck E; Huse K; Sack U; Bauer M; Schäfer A J Pharmacol Exp Ther; 2006 Aug; 318(2):762-71. PubMed ID: 16705081 [TBL] [Abstract][Full Text] [Related]
14. Evidence for antibiotic-mediated endotoxin release as a contributing factor to lethality in experimental gram-negative sepsis. Morrison DC; Bucklin SE Scand J Infect Dis Suppl; 1996; 101():3-8. PubMed ID: 9060044 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of endodontic treatment for endotoxin reduction in primarily infected root canals and evaluation of cytotoxic effects. Oliveira LD; Carvalho CA; Carvalho AS; Alves Jde S; Valera MC; Jorge AO J Endod; 2012 Aug; 38(8):1053-7. PubMed ID: 22794204 [TBL] [Abstract][Full Text] [Related]
16. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin. Mihas AA; Ceballos R; Mihas TA; Hirschowitz BI J Med; 1990; 21(6):301-11. PubMed ID: 2093097 [TBL] [Abstract][Full Text] [Related]
17. Augmenting effect of antibiotics on endotoxin activity may cause a safety problem. Yamamoto A; Sakai T; Ochiai M; Kamachi K; Kataoka M; Toyoizumi H; Arakawa Y; Horiuchi Y Microbiol Immunol; 2004; 48(2):97-102. PubMed ID: 14978334 [TBL] [Abstract][Full Text] [Related]
18. Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in D-galactosamine-sensitized mice. Gonzalez JC; Johnson DC; Morrison DC; Freudenberg MA; Galanos C; Silverstein R Infect Immun; 1993 Mar; 61(3):970-4. PubMed ID: 8432617 [TBL] [Abstract][Full Text] [Related]
19. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure. Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491 [TBL] [Abstract][Full Text] [Related]
20. Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis. Yuk SA; Kim H; Abutaleb NS; Dieterly AM; Taha MS; Tsifansky MD; Lyle LT; Seleem MN; Yeo Y Sci Adv; 2021 Aug; 7(32):. PubMed ID: 34362742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]